{
    "organizations": [],
    "uuid": "6f7b12fe81b882ed110621f27179b544f0ac2a01",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zealand-q1-net-sales-of-soliqua-10/brief-zealand-q1-net-sales-of-soliqua-100-33-and-lyxumia-adlyxin-at-eur-14-5-mln-idUSASO0003XJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Zealand Q1 Net Sales Of Soliqua 100/33 And Lyxumia/Adlyxin At EUR 14.5 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 27 (Reuters) - ZEALAND PHARMA A/S:\n* REG-ZEALAND ANNOUNCES NET SALES OF SOLIQUA® 100/33 AND LYXUMIA®/ADLYXIN® FOR THE FIRST QUARTER OF 2018\n* NET SALES OF SOLIQUA(®) 100/33 AND LYXUMIA(®)/ADLYXIN(®) OF EUR 14.5 MILLION/USD 17.9 MILLION IN Q1 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-27T13:46:00.000+03:00",
    "crawled": "2018-04-28T12:30:12.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "zealand",
        "pharma",
        "announces",
        "net",
        "sale",
        "first",
        "quarter",
        "net",
        "sale",
        "soliqua",
        "lyxumia",
        "eur",
        "million",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}